Coronavirus (COVID-19) Q&A

Interview with Steven Woloshin, MD, MS, author of At-Home Self-Testing Kits for SARS-CoV-2: A Randomized Trial Assessing How Consumers Interpret and Act on Possible Test Results. Hosted by Deborah Grady, MD, MPH.

Interview with Walter S. Gilliam, PhD, and Thomas S. Murray, MD, PhD, authors of Association of Child Masking With COVID-19–Related Closures in US Childcare Programs. Hosted by Angel Desai, MD.

Three members of President Biden’s former COVID-19 Advisory Board—Luciana Borio, MD, Ezekiel Emanuel, MD, PhD, and Mike Osterholm, PhD—discuss their recent JAMA Viewpoints, providing their ideas on strategies for public health as COVID-19 transitions from pandemic to endemic. Hosted by JAMA Associate Editor Preeti Malani, MD.

Related Content:

• A National Strategy for the “New Normal” of Life With COVID
• A National Strategy for COVID-19—Testing, Surveillance, and Mitigation Strategies
• A National Strategy for COVID-19 Medical Countermeasures
• Former Biden-Harris Transition Advisors Propose a New National Strategy for COVID-19
• Public Health in an Era of Endemic COVID-19 (video)

Former CDC Executive Secretariat of the Advisory Committee on Immunization Practices Amanda Cohn, MD, joins JAMA Associate Editor Preeti Malani, MD, for the latest on the need for vaccination and boosters, vaccine misinformation, and tackling the pandemic from a global perspective. Recorded January 6, 2022.

Related Content:

• One Year of COVID-19 Vaccines: A Shot of Hope, a Dose of Reality
• COVID-19 Vaccines Have Been Available in the US for More Than a Year—What’s Been Learned and What’s Next?
• COVID-19 CDC Update – Early January 2022

Infectious disease experts Adam Lauring, MD, PhD, and Carlos del Rio, MD, join JAMA Associate Editor Preeti Malani, MD, MSJ, for a discussion of the newly emerged Omicron variant, the potential for a 2021-2022 "twindemic" with flu, and the latest COVID-19 clinical updates. Recorded December 1, 2021.

Related content:

• Omicron Has Reached the US—Here’s What Infectious Disease Experts Know About the Variant
• COVID-19 Update: Omicron Variant

Interview with Cédric Lemogne, MD, PhD, and Joane Matta, PhD, authors of Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic. Hosted by Mitchell H. Katz, MD.

Read Transcript

COVID-19 Crisis Advances Efforts to Reimagine Nursing Homes; Moving COVID-19 Testing Out of the Clinic and Into the Home; The Lingua Franca of Addiction—Stigmatizing Words That Wound

Related Content:

• COVID-19 Crisis Advances Efforts to Reimagine Nursing Homes
• COVID-19 Testing Moves Out of the Clinic and Into the Home
• The Lingua Franca of Addiction—Stigmatizing Words That Wound

Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

The longstanding shortcomings of the US nursing home model became more visible during the COVID-19 crisis. Terry Fulmer, PhD, RN, a geriatric nurse practitioner and president of the John A. Hartford Foundation in New York City, discusses the challenges skilled nursing facilities face and shares her vision for nursing homes that better serve residents and support the workforce.

Related Content:

• COVID-19 Crisis Advances Efforts to Reimagine Nursing Homes
• Socially Assistive Robots Help Patients Make Behavioral Changes

Canadian law gives the country’s individual provinces and territories primary responsibility for coronavirus containment and mitigation. JAMA Associate Editor Preeti Malani, MD, MSJ, from the University of Michigan and Allan S. Detsky, MD, PhD, from the University of Toronto, Ontario, Canada, discuss the national pandemic experience, including public health responses to infection and vaccine allocation, from fall 2020 through summer 2021.

Related Content:

• COVID-19 in Canada: Experience and Response to Waves 2 and 3